Evidence map›Paper›PMID 19371792›Full record

ReviewMicrobes and infection2009

FOXP3 and the regulation of Treg/Th17 differentiation.

Steven F Ziegler, Jane H Buckner

Open access · greenAbstract readReview
In one paragraph

Review in Microbes and infection, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 174 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. CD4PeerJ · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Immune modulation of Th1/Th2/Treg/Th17/Th9/Th21 cells in rabbits infected withFrontiers in cellular and infection microbiology · 2023
    Article
  16. Review
  17. Review
  18. Review
  19. Outcome of Sublingual Immunotherapy in Allergic Rhinitis.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2021
    Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Steven F ZieglerImmunology, Benaroya Research Institute, Seattle, WA 98101, USA. sziegler@benaroyaresearch.org
Jane H Buckner
Benaroya Research InstituteBenteler (Czechia) · CZ

Funding

FOXP3: functional analysis of the gene mutated in miceR01AI048779 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2002 to 2006
$1.9M
NIAID NIH HHS R01 AI048779
6 · The paper itself

Abstract

CD4 T cell lineages are marked by the signature transcription factor each lineage expresses. For example, regulatory T cells (Tregs) are characterized by expression of FOXP3, which is either induced during thymic development for natural Tregs (nTregs), or in the periphery in the presence of TGF-beta and retinoic acid for induced Tregs (iTreg). Interestingly, recent work has shown that the signature transcription factor for Th17 cells, RORgammat, is also induced by TGF-beta, thus linking the differentiation of the Treg and Th17 lineages. In the absence of a second signal from a proinflammatory cytokine, FOXP3 can inhibit RORgammat function and drive Treg differentiation. However, when the cell also receives a signal from a proinflammation cytokine (e.g., IL-6), FOXP3 function is inhibited and the Th17 differentiation pathway is induced. Therefore, it is the balance between FOXP3 and RORgammat function that determines CD4 T cell fate and the type of immune response that will be generated.

Indexed as

Cell DifferentiationForkhead Transcription FactorsHumansInterleukin-17Lymphocyte SubsetsNuclear Receptor Subfamily 1, Group F, Member 3Receptors, Retinoic AcidReceptors, Thyroid HormoneT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryForkhead Transcription FactorsFOXP3 protein, humanInterleukin-17Nuclear Receptor Subfamily 1, Group F, Member 3Receptors, Retinoic AcidReceptors, Thyroid HormoneRORC protein, human

Identifiers

PMID19371792
PMCPMC2728495
OpenAlexW1980888912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.